Medical devices, healthcare technology and the business of care
PMA approval · P250028

Synergy Disc

Synergy Spine Solutions, Inc. · Decision date Feb 26, 2026

FDA DECISIONP250028

What did the FDA approve?

FDA records P250028 as an original PMA application. The recorded decision is approval, dated Feb 26, 2026.

FDA approval order statement

The Synergy Disc is indicated in skeletally mature patients for reconstruction of the disc at one level from C3-C7 following single-level discectomy for intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain, or myelopathy due to a single-level abnormality localized to the level of the disc space and at least one of the following conditions confirmed by radiographic imaging (CT, MRI, X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height compared to adjacent levels. The Synergy Disc is implanted using an anterior approach. Patients should have failed at least 6 weeks of conservative treatment or demonstrated progressive signs or symptoms despite nonoperative treatment prior to implantation of the Synergy Disc.
Regulatory pathway
Original PMA
Clinical specialty
Orthopedic
Decision date
Feb 26, 2026

FDA source record

Regulatory record facts

Identifier
P250028
Regulatory pathway
Premarket approval application
Product code
MJO
Decision code
APPR
Decision date
Feb 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P250028 received

    Application receipt date recorded by FDA.

  2. P250028 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P250028. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250028

Product / regulatory recordCompanyPathwayDecision dateSource
Synergy DiscP250028/S003
Synergy Spine Solutions, Inc.PMA supplementSep 17, 2026FDA

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
prodisc C NovaP070001/S031
Centinel Spine, LLCPMA supplementSep 9, 2026FDA
Spineart USA, Inc.PMA approvalAug 10, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Synergy Spine Solutions, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
357 S. Mccaslin Blvd., Suite 120, Louisville, CO, 80027

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records